THANK YOU FOR SUBSCRIBING
Pharma Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Pharma Tech Outlook
Pharma Tech Outlook recognizes the VP of Research & Development of the Year - 2026 who are driving innovation in drug research, accelerating trial timelines, and ensuring scientific rigor from lab to market. These individuals have demonstrated exceptional leadership in navigating regulatory complexity, embracing data-driven methodologies, and advancing patient-centric development strategies.
Vice President, R&D, Direct Biologics
Kevin Hicok is Vice President of R&D at Direct Biologics, where he leads research and development programming for an emerging therapeutic modality based on an extracellular vesicle-enriched secretome. Drawing on more than 30 years in cell science, he brings experience across cell agriculture, regenerative cell technology and biologics development to guide research strategy, scientific programs and team leadership.
